• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人的药物代谢动力学及毒理学问题。

ADME-tox issues for the elderly.

作者信息

Hilmer Sarah N

机构信息

Royal North Shore Hospital, Ward 11C Main Building, Pacific Highway, St Leonards NSW 2065, Australia.

出版信息

Expert Opin Drug Metab Toxicol. 2008 Oct;4(10):1321-31. doi: 10.1517/17425255.4.10.1321.

DOI:10.1517/17425255.4.10.1321
PMID:18798701
Abstract

BACKGROUND

The elderly, defined as people aged >65 years, are a heterogeneous population. With increasing age there is increased prevalence of disease for which medication may be indicated and increased drug toxicity.

OBJECTIVE/METHODS: This review of the published scientific and clinical data on absorption, distribution, metabolism, excretion and toxicity (ADME-tox) in old age informs prescribers and drug developers of age-related factors that determine drug dose, safety and efficacy.

RESULTS/CONCLUSION: Increased inter-individual variability is a major feature of toxicology in old age. Changes in ADME-tox associated with normal ageing are currently better described than changes in the frail aged. Reduced hepatic and renal clearance are the most significant toxicokinetic changes seen in normal ageing. Drug toxicity in old age is influenced by changes in the quantity, affinity and responsiveness of drug targets, physiologic reserve and response to injury. Further investigation of the effects of medications on cognitive and physical functions in older adults is required.

摘要

背景

老年人定义为年龄大于65岁的人群,是一个异质性群体。随着年龄增长,需要药物治疗的疾病患病率增加,药物毒性也增加。

目的/方法:本综述对已发表的关于老年人吸收、分布、代谢、排泄和毒性(ADME-tox)的科学和临床数据进行了分析,旨在向开处方者和药物研发人员介绍决定药物剂量、安全性和疗效的年龄相关因素。

结果/结论:个体间变异性增加是老年毒理学的一个主要特征。与正常衰老相关的ADME-tox变化目前比体弱老年人的变化描述得更好。肝和肾清除率降低是正常衰老中最显著的毒代动力学变化。老年药物毒性受药物靶点数量、亲和力和反应性、生理储备以及对损伤的反应变化影响。需要进一步研究药物对老年人认知和身体功能的影响。

相似文献

1
ADME-tox issues for the elderly.老年人的药物代谢动力学及毒理学问题。
Expert Opin Drug Metab Toxicol. 2008 Oct;4(10):1321-31. doi: 10.1517/17425255.4.10.1321.
2
Pharmacokinetic and pharmacodynamic alterations in older people with dementia.老年人痴呆症患者的药代动力学和药效学改变。
Expert Opin Drug Metab Toxicol. 2017 Jun;13(6):651-668. doi: 10.1080/17425255.2017.1325873. Epub 2017 May 10.
3
ADME/tox comes of age: twenty years later.ADME/tox 崭露头角:二十年后。
Xenobiotica. 2024 Jul;54(7):352-358. doi: 10.1080/00498254.2023.2245049. Epub 2023 Aug 8.
4
In silico ADME-Tox modeling: progress and prospects.计算机辅助药物代谢动力学-药物毒性建模:进展与展望。
Expert Opin Drug Metab Toxicol. 2017 Nov;13(11):1147-1158. doi: 10.1080/17425255.2017.1389897. Epub 2017 Oct 13.
5
Comparative pharmacokinetic changes and drug therapy in an older population.老年人群的比较药代动力学变化及药物治疗
J Am Geriatr Soc. 1982 Nov;30(11 Suppl):S11-9. doi: 10.1111/j.1532-5415.1982.tb01351.x.
6
Drug metabolism and ageing.药物代谢与衰老
J Br Menopause Soc. 2005 Jun;11(2):51-6. doi: 10.1258/136218005775544589.
7
Predictive Multitask Deep Neural Network Models for ADME-Tox Properties: Learning from Large Data Sets.用于 ADME-Tox 性质的预测性多任务深度神经网络模型:从大数据集学习。
J Chem Inf Model. 2019 Mar 25;59(3):1253-1268. doi: 10.1021/acs.jcim.8b00785. Epub 2019 Jan 24.
8
Two-dimensional (2D) in silico models for absorption, distribution, metabolism, excretion and toxicity (ADME/T) in drug discovery.药物发现中吸收、分布、代谢、排泄和毒性(ADME/T)的二维(2D)计算模型。
Curr Top Med Chem. 2010;10(1):116-26. doi: 10.2174/156802610790232224.
9
Drug dosage in the elderly. Is it rational?老年人的药物剂量。合理吗?
Drugs Aging. 1998 Nov;13(5):357-79. doi: 10.2165/00002512-199813050-00003.
10
Organs-on-a-chip: Current applications and consideration points for in vitro ADME-Tox studies.芯片器官:体外药物吸收、分布、代谢和排泄-毒理学(ADME-Tox)研究的当前应用及考虑要点
Drug Metab Pharmacokinet. 2018 Feb;33(1):49-54. doi: 10.1016/j.dmpk.2018.01.003. Epub 2018 Jan 11.

引用本文的文献

1
Ethnicity and Socioeconomic Disparities in Clinical Trial Participation for Ovarian Cancer: A Retrospective Observational Study in London.卵巢癌临床试验参与中的种族与社会经济差异:伦敦的一项回顾性观察研究
Cancers (Basel). 2024 Oct 24;16(21):3590. doi: 10.3390/cancers16213590.
2
Gabapentinoids: a therapeutic review.加巴喷丁类药物:治疗综述
Aust Prescr. 2023 Dec;46(4):80-85. doi: 10.18773/austprescr.2023.025.
3
Pharmacokinetics of Antibacterial Agents in the Elderly: The Body of Evidence.老年人抗菌药物的药代动力学:证据主体
Biomedicines. 2023 Jun 4;11(6):1633. doi: 10.3390/biomedicines11061633.
4
Association Between Frailty and Antiseizure Medication Tolerability in Older Adults With Epilepsy.老年人癫痫与抗癫痫药物耐受性的脆弱性关联。
Neurology. 2023 Mar 14;100(11):e1135-e1147. doi: 10.1212/WNL.0000000000201701. Epub 2022 Dec 19.
5
Deprescribing in older people.老年人的减药管理
Aust Prescr. 2020 Aug;43(4):114-120. doi: 10.18773/austprescr.2020.033. Epub 2020 Aug 3.
6
Persistence with antihypertensives in uncomplicated treatment-naïve very elderly patients: a nationwide population-based study.初治无并发症的高龄患者抗高血压药物的持续性:一项基于全国人群的研究。
BMC Cardiovasc Disord. 2017 Aug 24;17(1):232. doi: 10.1186/s12872-017-0665-4.
7
Clinical Relevance of Differences in Glomerular Filtration Rate Estimations in Frail Older People by Creatinine- vs. Cystatin C-Based Formulae.基于肌酐与胱抑素C的公式估算衰弱老年人肾小球滤过率差异的临床相关性
Drugs Aging. 2017 Jun;34(6):445-452. doi: 10.1007/s40266-017-0460-z.
8
Medication appropriateness tool for co-morbid health conditions in dementia: consensus recommendations from a multidisciplinary expert panel.痴呆症共病健康状况的药物适宜性工具:多学科专家小组的共识建议
Intern Med J. 2016 Oct;46(10):1189-1197. doi: 10.1111/imj.13215.
9
Prescribing for Australians living with dementia: study protocol using the Delphi technique.为澳大利亚痴呆症患者开处方:运用德尔菲技术的研究方案
BMJ Open. 2015 Aug 11;5(8):e008048. doi: 10.1136/bmjopen-2015-008048.
10
Drug-induced liver injury in older adults.老年人药物性肝损伤
Ther Adv Drug Saf. 2010 Dec;1(2):65-77. doi: 10.1177/2042098610386281.